Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11)

Susan J. Zunino, David H. Storms, Jonathan M Ducore

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Acute lymphoblastic leukemia (ALL) with translocation t(4;11) is found in 60-85% of infants with ALL and is often refractory to conventional chemotherapeutics after relapse. Using the t(4;11) ALL line SEM, we evaluated chemotherapy resistance in NOD.CB17-Prkdcscid/J mice. SEM cells were injected into the tail vein and engraftment was monitored by flow cytometry. Once engraftment was observed, mice were injected intraperitoneally with phosphate-buffered saline (PBS), or vincristine (0.5. mg/kg body weight) three times per week for 4. weeks (n=8 per group). The level of P-glycoprotein in SEM cells was increased 3-fold by vincristine treatment compared to PBS-treated mice. Survival curves showed that leukemia cell growth was initially delayed by vincristine treatment, but the mice eventually succumbed to disease. These data describe a novel inducible model for investigating multi-drug resistance mechanisms in high-risk t(4;11) ALL.

Original languageEnglish (US)
Pages (from-to)49-54
Number of pages6
JournalCancer Letters
Volume296
Issue number1
DOIs
StatePublished - Oct 2010

Fingerprint

Genetic Translocation
Multiple Drug Resistance
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Vincristine
Phosphates
P-Glycoprotein
Tail
Veins
Flow Cytometry
Leukemia
Body Weight
Recurrence
Drug Therapy
Therapeutics
Growth

Keywords

  • Leukemia
  • Multi-drug resistance
  • P-glycoprotein
  • Translocation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11). / Zunino, Susan J.; Storms, David H.; Ducore, Jonathan M.

In: Cancer Letters, Vol. 296, No. 1, 10.2010, p. 49-54.

Research output: Contribution to journalArticle

@article{1a824e697d9c42c7a93a78e5636a284b,
title = "Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11)",
abstract = "Acute lymphoblastic leukemia (ALL) with translocation t(4;11) is found in 60-85{\%} of infants with ALL and is often refractory to conventional chemotherapeutics after relapse. Using the t(4;11) ALL line SEM, we evaluated chemotherapy resistance in NOD.CB17-Prkdcscid/J mice. SEM cells were injected into the tail vein and engraftment was monitored by flow cytometry. Once engraftment was observed, mice were injected intraperitoneally with phosphate-buffered saline (PBS), or vincristine (0.5. mg/kg body weight) three times per week for 4. weeks (n=8 per group). The level of P-glycoprotein in SEM cells was increased 3-fold by vincristine treatment compared to PBS-treated mice. Survival curves showed that leukemia cell growth was initially delayed by vincristine treatment, but the mice eventually succumbed to disease. These data describe a novel inducible model for investigating multi-drug resistance mechanisms in high-risk t(4;11) ALL.",
keywords = "Leukemia, Multi-drug resistance, P-glycoprotein, Translocation",
author = "Zunino, {Susan J.} and Storms, {David H.} and Ducore, {Jonathan M}",
year = "2010",
month = "10",
doi = "10.1016/j.canlet.2010.03.017",
language = "English (US)",
volume = "296",
pages = "49--54",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11)

AU - Zunino, Susan J.

AU - Storms, David H.

AU - Ducore, Jonathan M

PY - 2010/10

Y1 - 2010/10

N2 - Acute lymphoblastic leukemia (ALL) with translocation t(4;11) is found in 60-85% of infants with ALL and is often refractory to conventional chemotherapeutics after relapse. Using the t(4;11) ALL line SEM, we evaluated chemotherapy resistance in NOD.CB17-Prkdcscid/J mice. SEM cells were injected into the tail vein and engraftment was monitored by flow cytometry. Once engraftment was observed, mice were injected intraperitoneally with phosphate-buffered saline (PBS), or vincristine (0.5. mg/kg body weight) three times per week for 4. weeks (n=8 per group). The level of P-glycoprotein in SEM cells was increased 3-fold by vincristine treatment compared to PBS-treated mice. Survival curves showed that leukemia cell growth was initially delayed by vincristine treatment, but the mice eventually succumbed to disease. These data describe a novel inducible model for investigating multi-drug resistance mechanisms in high-risk t(4;11) ALL.

AB - Acute lymphoblastic leukemia (ALL) with translocation t(4;11) is found in 60-85% of infants with ALL and is often refractory to conventional chemotherapeutics after relapse. Using the t(4;11) ALL line SEM, we evaluated chemotherapy resistance in NOD.CB17-Prkdcscid/J mice. SEM cells were injected into the tail vein and engraftment was monitored by flow cytometry. Once engraftment was observed, mice were injected intraperitoneally with phosphate-buffered saline (PBS), or vincristine (0.5. mg/kg body weight) three times per week for 4. weeks (n=8 per group). The level of P-glycoprotein in SEM cells was increased 3-fold by vincristine treatment compared to PBS-treated mice. Survival curves showed that leukemia cell growth was initially delayed by vincristine treatment, but the mice eventually succumbed to disease. These data describe a novel inducible model for investigating multi-drug resistance mechanisms in high-risk t(4;11) ALL.

KW - Leukemia

KW - Multi-drug resistance

KW - P-glycoprotein

KW - Translocation

UR - http://www.scopus.com/inward/record.url?scp=77954762562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954762562&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2010.03.017

DO - 10.1016/j.canlet.2010.03.017

M3 - Article

VL - 296

SP - 49

EP - 54

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -